Randox Biosciences

Activities: Analysis

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Pharmaceutical

Showcasing advancements in biotechnology

World-leading medical diagnostics manufacturer Randox Laboratories, is showcasing advancements in biotechnology at the world’s largest diagnostics conference, being held in Chicago, Illinois

Randox exhibit diagnostic innovations at Oncology Congress

Diagnostic firm Randox Laboratories sent a delegation of scientists from its Biosciences Division to take part in the UK Exhibition of Oncology Excellence, which is taking place this week in Beijing and Guangzhou, China
Research & Development

£50m Randox Centres of Excellence launched in Northern Ireland

A record £50 million investment, which will deliver cutting-edge technologies to diagnose conditions like cancer, heart conditions and infectious diseases has been announced by Northern Ireland diagnostics company Randox Laboratories and Invest NI
Analysis

Bosch Healthcare solutions develops a new all-in-one solution for molecular laboratory diagnostics

Vivalytic is designed to be an open platform compatible with molecular diagnostic tests of various manufacturers, including Randox Laboratories
Pharmaceutical

Transgene and Randox to develop innovative multifunctional oncolytic virotherapies for solid tumors

Novel oncolytic virotherapies will be developed by Transgene, based on its next generation Invir.IO Platform and expressing Randox’ single-domain antibodies (SdAb)
Design & Build

Randox to create 540 jobs in Northern Ireland with new £161m Randox Science Park

Manufacturing and R&D centre will accelerate the development of new products to treat a range of diseases
Manufacturing

Chemistry controls streamline QC in medical laboratories

Save time and money while ensuring highly accurate results
Subscribe now